-
Recent Posts
- Coronavirus today and the SCI community tomorrow
- Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: food and drug administration fda
Developing Partnerships with Patients: Salina Prasad and Steve Morin of the FDA
With increasing attention toward patient-centric drug development, patients play an integral and growing role in the development of therapeutic products. Patient organizations are engaging in basic disease research, working with medical product developers and providing meaningful input to regulators. Through … Continue reading
Posted in Uncategorized
Tagged FDA, food and drug administration fda, Salina Prasad, Steve L Morin
Comments Off on Developing Partnerships with Patients: Salina Prasad and Steve Morin of the FDA
Statement Regarding Potential Budget Cuts to the FDA and NIH: Unite 2 Fight Paralysis is the Voice of the Cure
The Alliance for Regenerative Medicine (ARM), the advocacy voice for regenerative medicine, has significant concerns about the automatic budget cuts to the US Food and Drug Administration (FDA) and National Institutes of Health (NIH) scheduled to take affect on January … Continue reading
Posted in Regenerative Medicine
Tagged advocacy voice, arm Alliance for Regenerative Medicine, FDA, food and drug administration fda, national institutes of health nih, science, spinal cord injury research, U2FP, Voice of the Cure
Comments Off on Statement Regarding Potential Budget Cuts to the FDA and NIH: Unite 2 Fight Paralysis is the Voice of the Cure